2m 2m 2m 2m 2m 2m 2m
Orgenesis (ORGS)
OTC
$1.25+$0.66 (+111.86%)
Price as of Oct 24, 2024 3:59 PM EDT- $7.3MMarket Cap
- -66.29%1-Year Change
- BiotechnologyIndustry
Orgenesis (ORGS)
$1.25+$0.66 (+111.86%)
ORGS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.59 | ||
Change | +$0.10 (+19.19%) | ||
Open | $0.59 | ||
High | $0.59 | ||
Low | $0.59 | ||
Previous Close | $0.49 | ||
Volume | 100 | ||
30-Day Average Volume | 2,126 | ||
1-Week Change | 31.11% | ||
1-Month Change | 47.50% | ||
1-Year Change | -66.29% | ||
3-Year Change | -95.00% | ||
5-Year Change | -98.84% | ||
Fundamentals | |||
Shares Outstanding | 4.7M | ||
Total Assets | $30.9M | ||
Market Cap | $7.3M | ||
Enterprise Value | $33.2M | ||
Period: QTR TTM FY | |||
Revenue | $141,000.00 | ||
Net Income | -$9.8M | ||
Free Cash Flow | -$4.6M | ||
EBIT | -$9.7M | ||
EBITDA | -$9.4M | ||
Net Working Capital | -$27.1M | ||
EPS | $0.29 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | 235 | ||
P/B | -0 | ||
P/E | 5 | ||
PEG | 0 | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 09/25/2024 | ||